Actualités 30. Apr. 2024 Les Grands Titres de Suisse occidentale (Avril 2024) De percées biotechnologiques à la transformation des essais cliniques, en passant par des avancées dans le domaine des matériaux écologiques et d...
News 30. Apr. 2024 Top Stories from Western Switzerland (April 2024) From biotech breakthroughs and the transformation of clinical trials to advancements in eco-friendly materials and renewable energy initiatives, ...
Press Release 23. Apr. 2024 Xovis AG wins Switzerland Global Enterprise’s 2024 Export Award Since its establishment in 2008, Xovis AG has become a global leader in intelligent people flow management. Around 95 percent of its sales are ge...
Success stories 27. März 2024 Lombardi – Swiss Engineering to Combat Climate Change The Lombardi Group, based in Giubiasco/TI, provides engineering services for demanding transport, underground and water-related infrastructures, ...
News 06. Nov. 2023 Vaud-based LAGOSTA and global giant Merck collaborate on chitosan distribution Biotech company LAGOSTA has announced a collaboration with Merck. The partnership aims to facilitate the distribution of LAGOSTA's superior chito...
Aktuell 06. Mai 2024 EY meldet Plus von 53 Prozent bei Investitionen in der Schweiz Ausländische Investitionen in Europa sind 2023 um 4 Prozent gesunken. Die Investitionen in der Schweiz sind dagegen um 53 Prozent gestiegen. Das ...
Success stories 25. Apr. 2024 Xovis – measuring people flows around the world with Swiss precision Since its establishment in 2008, Xovis AG has become a global leader in intelligent people flow management. 300,000 Xovis sensors are in use in a...
Actualités 06. Nov. 2023 LAGOSTA et le géant mondial Merck collaborent pour la distribution de chitosan La société biotechnologique LAGOSTA a annoncé une collaboration avec Merck. Ce partenariat vise à faciliter la distribution du chitosan de qualit...
News 17. Apr. 2024 Addex Therapeutics launches spin-off Neurosterix in Geneva with USD 63 million investment Geneva's Addex Therapeutics has teamed up with Perceptive Advisors to launch spin-off Neurosterix, a new player in neurology-focused drug develop...
Success stories 31. Jan. 2023 BÜCHI Labortechnik: Konsequente Go-to-Market-Strategie BÜCHI Labortechnik generiert 97% des Umsatzes im Ausland. Mit 20 Tochtergesellschaften und zahlreichen Vertriebspartnern auf allen Kontinenten ve...
Comunicati Stampa 23. Apr. 2024 Xovis SA vince l’Export Award 2024 di Switzerland Global Enterprise Dalla sua creazione nel 2008, Xovis SA è diventata leader mondiale nella gestione intelligente dei flussi di persone. L’azienda realizza quasi il...
News 09. Aug. 2023 Bühler collaborating with Ikawa for coffee roasting The technology company Bühler from the canton of St.Gallen has entered into a strategic partnership with Ikawa, the British manufacturer of coffe...
Actualités 23. Aug. 2023 Click Analytic lève USD 600’000 pour repenser le marketing d’influence La start-up genevoise Click Analytic a annoncé la clôture réussie de son tour de financement préliminaire, levant USD 600’000 auprès d'un mélange...
News 06. Mai 2024 EY reports growth of 53 percent for investments in Switzerland Foreign investments in Europe fell by 4 percent in 2023. However, investments in Switzerland were up by 53 percent. These findings were reported ...
News 29. Febr. 2024 Top Stories from Western Switzerland (February 2024) From significant strides in semiconductor innovation and breakthroughs in medical research to strategic advancements in fintech and medtech secto...
Success stories 31. Jan. 2023 BÜCHI Labortechnik: strategia go-to-market coerente BÜCHI Labortechnik genera il 97% del suo fatturato all’estero e, con le sue 20 filiali e i suoi numerosi partner di vendita in tutti i ...
Actualités 17. Apr. 2024 Addex Therapeutics lance la spin-off Neurosterix à Genève avec un investissement de USD 63 millions La société genevoise Addex Therapeutics s’est associée à Perceptive Advisors pour lancer la spin-off Neurosterix, un nouvel acteur dans le dévelo...
Communiqués de Presse 23. Apr. 2024 Xovis remporte l’Export Award 2024 de Switzerland Global Enterprise Depuis sa création en 2008, Xovis SA est devenue un leader mondial de la gestion intelligente des flux de personnes. La société réalise près de 9...